Bomback, A. S., Herlitz, L. C., Kedia, P. P., Petersen, J., Yue, H., & Lafayette, R. A. (2025). Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial. Journal of the American Society of Nephrology, 36(3), 487-499. https://doi.org/10.1681/ASN.0000000526
Chicago Style (17th ed.) CitationBomback, Andrew S., Leal C. Herlitz, Priyanka Punit Kedia, Jeffrey Petersen, Huibin Yue, and Richard A. Lafayette. "Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial." Journal of the American Society of Nephrology 36, no. 3 (2025): 487-499. https://doi.org/10.1681/ASN.0000000526.
MLA (9th ed.) CitationBomback, Andrew S., et al. "Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial." Journal of the American Society of Nephrology, vol. 36, no. 3, 2025, pp. 487-499, https://doi.org/10.1681/ASN.0000000526.